New data indicates that retatrutide, a dual-action medication, could represent a major step in size loss . This therapy combines the effects of a GLP-1 agonist and a GIP receptor , seemingly offering a https://myfirstbookmark.com/story21643428/the-new-promise-for-weight-regulation